Health and Medicine
-
August 20, 2014
Enzyme holds the door for influenza
Compounds developed at Vanderbilt University may offer a new way to block influenza infection. -
August 19, 2014
Keeping an eye on blast trauma
Understanding the cellular and molecular responses of the eye to blast injury could guide new treatment development. -
August 15, 2014
Vanderbilt enrolling children with autism in medication-related weight gain study
Vanderbilt University is one of four sites in the United States and Canada to enroll children with autism in a study to examine weight gain commonly experienced while taking antipsychotic medication. -
August 15, 2014
Weight regain after gastric bypass
Early weight regain after gastric bypass surgery does not reverse metabolic improvements, and the "hunger hormone" ghrelin might indicate who is susceptible to weight regain. -
August 14, 2014
Team takes 4-D look at brain receptor’s role
Reporting last week in the journal Cell, researchers from Oregon Health and Science University, Harvard Medical School and Vanderbilt University describe the first “four-dimensional” picture of a brain receptor that plays a key role in learning and memory. -
August 14, 2014
Growth factor blockade targets breast tumors
Inhibition of BMP growth factor signaling reduces breast tumor burden and metastasis. -
August 13, 2014
High-dose flu vaccine more effective in elderly, Vanderbilt-led study shows
High-dose influenza vaccine is 24 percent more effective than the standard-dose vaccine in protecting persons ages 65 and over against influenza illness and its complications.